Skip to main content
main-content

05.08.2019 | Inflammatory Disorders | Ausgabe 11/2019

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2019

Visual acuity loss and development of ocular complications in white dot syndromes: a longitudinal analysis of 3 centers

Zeitschrift:
Graefe's Archive for Clinical and Experimental Ophthalmology > Ausgabe 11/2019
Autoren:
Lara Borrego-Sanz, Alejandro Gómez-Gómez, María Gurrea-Almela, Mar Esteban-Ortega, Esperanza Pato, David Díaz-Valle, Teresa Díaz-Valle, Santiago Muñoz-Fernández, Luis Rodriguez-Rodriguez, the Madrid Uveitis Study Group
Wichtige Hinweise

Electronic supplementary material

The online version of this article (https://​doi.​org/​10.​1007/​s00417-019-04429-5) contains supplementary material, which is available to authorized users.
Teresa Díaz-Valle, Santiago Muñoz-Fernández and Luis Rodriguez-Rodriguez contributed equally to this work.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Abstract

Purpose

To compare the clinical prognosis among selected white dot syndromes (WDS) (birdshot chorioretinopathy (BRC), multifocal choroiditis, serpiginous choroidopathy (SC), and others) and to identify risk factors of poor visual prognosis.

Methods

Retrospective longitudinal cohort study including 84 patients (143 affected eyes) diagnosed with WDS between 1982 and July 2017, followed up until loss of follow-up or December 2017, and recruited from three Uveitis Clinics (Madrid Community, Spain). Our main outcome measures were temporary or permanent moderate (corrected visual acuity in the Snellen scale < 20/50) or severe (< 20/200) vision losses, and development of new ocular complications. Incidence rates (IR) of the main outcome measures were estimated per 100 eye-years. Bivariate and multivariate Cox robust regression models analyzed the association of demographic- and clinical-related variables with vision loss.

Results

SC exhibited the greatest IR of vision loss, even in the multivariate models. Previous events of vision loss, presence of choroidal neovascularization, and cataracts exhibited worse visual prognosis. Monotherapy with immunosuppressive drugs but not combine therapy was also associated with higher IR of visual loss. Regarding new ocular complications, BRC showed the highest IR of epiretinal membrane and macular edema.

Conclusions

SC presents the worst visual prognosis. Some ocular manifestations can identify patients with WDS at risk of a worse clinical evolution.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

★ PREMIUM-INHALT
e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Zusatzmaterial
Nur für berechtigte Nutzer zugänglich
Literatur
Über diesen Artikel

Weitere Artikel der Ausgabe 11/2019

Graefe's Archive for Clinical and Experimental Ophthalmology 11/2019 Zur Ausgabe

Neu im Fachgebiet Augenheilkunde

25.03.2020 | Leitthema | Ausgabe 4/2020

Rechtliche Aspekte der Qualitätssicherung

Beispiel der intravitrealen operativen Injektionstherapie